Development of T2D is initially characterized by decreased insulin sensitivity, manifested by ensuing hyperglycemia and a compensatory response where pancreatic β-cells produce and secrete more insulin, which in turn results in hyperinsulinemia. This evidence concerns the gene INS and Hyperinsulinemia.